FDA Panel Overwhelmingly Rejects MDMA Psychedelic as Mental Health Treatment
CCHR applauds the panel’s decision amid concerns over biased clinical trials and risks such as heart attacks, strokes, psychosis, and sexual abuse of patients during…
Tag Archives: psilocybin
CCHR Calls for Ceasing Psychedelic Drug Trials on Military and Veterans
Mental health industry watchdog calls for an end to federal funding for psychedelic drug research on active-duty service members and veterans, likening it to the…
CCHR Cautions Legislators as FDA Weighs Approval of Psychedelics Amid Rising Violence
Mental health watchdog says adding psychedelics as approved mental health treatment will fuel more acts of drug-induced violence in the community. By Jan EastgatePresident, CCHR…
Aussie psychiatrists McGorry and Hickie—More Brave New World Tricks—Tripping Out Autistic Young Adults with Psychedelics
MDMA and psilocybin psychiatric research is a bad “trip” for mental health in Australia, U.S. and globally. By CCHR International The Mental Health Industry Watchdog…
CCHR Warns Against Psychedelic Trips Potentially Planned for 55m Americans, including Teens
Mental health industry watchdog expands its investigation into failed psychedelic “solutions” being marketed to treat mental issues, citing latest questionable survey By CCHR International The…